What is staurosporine, and is it in clinical trials?
Staurosporine is a natural product kinase inhibitor best known in preclinical research. The provided information does not include any clinical trial details (such as a trial registry entry, study phase, sponsor, or results), so a specific “staurosporine clinical trial” cannot be confirmed from the available context.
How would I find the exact staurosporine clinical trial listing?
To locate the correct clinical study entry, search the public trial registries by using these terms:
- “staurosporine”
- “staurosporine” plus “phase 1” or “phase 2”
- “staurosporine” plus “inhibitor”
- (If you know the sponsor or indication) add the company or disease name.
If you share the intended indication (for example, cancer type) or the trial identifier (e.g., NCT number, EudraCT number), I can help interpret what that specific record says.
Are staurosporine analogs more likely to have clinical development?
Because staurosporine itself is widely used as a research tool and prototype kinase inhibitor, developers often move toward optimized analogs with improved selectivity, potency, and safety. If your goal is to find clinically tested drug candidates related to staurosporine, searching by “staurosporine analog” or “staurosporine-derived” may surface more relevant clinical listings.
What trial details should I look for once I find a record?
When you open the registry page, the key items to extract are:
- phase (1/2/3)
- sponsor and study sites
- target indication and eligibility criteria
- dosing schedule and route
- primary endpoint(s)
- status (recruiting, active, completed, terminated)
- results (if posted)
If you meant a specific staurosporine trial, what do you need to share?
Reply with any one of the following, and I’ll tailor the answer to the exact trial:
- NCT number (or EudraCT)
- sponsor/company name
- disease/indication
- whether you want current recruiting studies or completed/terminated ones
Sources
No sources were provided with the question, and none are available in the prompt to cite.